Auro Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 239365, "name": "Auro Labs.", "stock_name": "Auro Labs.", "full_name": "Auro Laboratories Ltd", "name_url": "stocks-analysis/auro-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "234.75", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "234.75", "mcapval": "146.31 Cr", "mcap": "Micro Cap", "scripcode": 530233, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE292C01011", "curr_date": "Aug 10, 12:00 PM", "curr_time": "12:01 PM", "last_traded_at": "Aug 10, 12:00 PM IST", "bse_nse_vol": "195 ", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/auro-labs-239365-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Auro Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-4140313", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_dealthcross_4140313.png", "date": "2026-08-06 18:00:27", "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook." }, { "title": "Auro Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4130019", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4130019.png", "date": "2026-07-31 10:11:38", "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Auro Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4108933", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4108933.png", "date": "2026-07-20 10:10:58", "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Auro Laboratories Ltd Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-valuation-concerns-4094493", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4094493.png", "date": "2026-07-09 08:06:22", "description": "Auro Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 July 2026, reflecting a marked deterioration in its technical outlook and persistent fundamental challenges. Despite a positive quarterly financial performance, the company’s valuation, financial trends, and technical indicators have collectively triggered this reassessment, signalling caution for investors in this micro-cap pharmaceutical player." }, { "title": "Auro Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4090671", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4090671.png", "date": "2026-07-06 10:10:31", "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Auro Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4070297", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_mojoScore_4070297.png", "date": "2026-06-24 10:10:25", "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Auro Laboratories Declines 8.40% Amid Margin Pressures and Quality Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-declines-840-amid-margin-pressures-and-quality-downgrade-4053090", "imagepath": "", "date": "2026-06-14 14:03:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Stock opens at Rs.267.65, down 3.55% amid broader market weakness</p>\n <p><strong>3 June:</strong> Quarterly results reveal strong revenue growth but margin pressures</p>\n <p><strong>4 June:</strong> Quality rating downgraded to below average, highlighting fundamental concerns</p>\n <p><strong>5 June:</strong> Week closes at Rs.254.20, down 1.05% on heavy volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.277.50</div></div>\n <div class=\"stat-item\"><div class=\"..." }, { "title": "Auro Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-4048934", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_mojoScore_4048934.png", "date": "2026-06-12 10:10:24", "description": "Auro Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Auro Laboratories Ltd Downgraded to Below Average Quality Amid Declining Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-downgraded-to-below-average-quality-amid-declining-fundamentals-4035074", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AuroLaboratorie_qualitydot_4035074.png", "date": "2026-06-04 08:00:05", "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grading downgraded from Hold to Sell, reflecting a notable deterioration in its business fundamentals. Key financial parameters such as return on equity (ROE), return on capital employed (ROCE), and growth metrics have weakened, raising concerns about the company’s operational efficiency and financial health amid a challenging industry backdrop." } ], "total": 172, "sid": "239365", "stock_news_url": "https://www.marketsmojo.com/news/auro-laboratories-239365" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "20-Jul-2026", "details": "With reference to Regulation 47 of SEBI (LODR) Regulations 2015 attached herewith newspaper cuttings of Public Notice of the 37th AGM information on evoting and other related information.", "source": "BSE" }, { "caption": "Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday August 11 2026", "datetime": "16-Jul-2026", "details": "Enclosed Notice of 37th Annual General Meeting of the Company scheduled on August 11 2026 at 11:30a.m. (IST)", "source": "BSE" }, { "caption": "Regulation 36(1)(B) Of SEBI (LODR) Regulations 2015", "datetime": "16-Jul-2026", "details": "The Letter being send to the shareholders containing the web-link of the Annual Report of the Company for the FY 2025-2026 is enclosed.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Stock opens at Rs.267.65, down 3.55% amid broader market weakness

3 June: Quarterly results reveal strong revenue growth but margin pressures

4 June: Quality rating downgraded to below average, highlighting fundamental concerns

5 June: Week closes at Rs.254.20, down 1.05% on heavy volume

Week Open

Rs.277.50

Read full news article

Auro Laboratories Ltd is Rated Sell

2026-06-12 10:10:24

Auro Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd Downgraded to Below Average Quality Amid Declining Fundamentals

2026-06-04 08:00:05

Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grading downgraded from Hold to Sell, reflecting a notable deterioration in its business fundamentals. Key financial parameters such as return on equity (ROE), return on capital employed (ROCE), and growth metrics have weakened, raising concerns about the company’s operational efficiency and financial health amid a challenging industry backdrop.

Read full news article